using statistical models to assess medical cost of hepatitis c virus

نویسندگان

mohsen vahedi

asma pourhoseingholi

sara ashtari

mohamad amin pourhoseingholi phd.

چکیده

aim : this study compared pr and nb in predicting hcv patient costs. the objective of this study was to predict the direct cost of the hcv patient in iran. background : hepatitis c virus (hcv) is a common and expensive infectious disease in iran. cost associated with hcv and its complications has not been well characterized. analysis of cost data is important in providing consistent information to aid budgeting decisions and certain statistical regression models need for prediction mean costs. poisson regression (pr) and negative binomial regression (nb) are more common in cost prediction study. patients and methods : this study designed as a cross-sectional clinic base from 2001 to 2010. first treatment period of each patient bring in study. we evaluated the doctor visiting, drugs, and hospitalization and laboratory tests of patients. cost per person per one treatment period estimated in purchasing power parity dollars (ppp$). the pr is one of the models from general linear models (glm) for describing count outcomes. the nb is another model from (glm) as an alternative to the pr model. results : according to likelihood ratio test nb was found to be more appropriate than pr (p<0.001). genotype, marriage, medication, and svr were being significant. genotype 3 versus 1 decreasing cost while marriage, consuming pegasys and svr increasing. conclusion : choosing best model in cost data is important because of specific feature of this data. after fitting the best model, analyzing and predicting future cost for patient in different situation is possible.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Using statistical models to assess medical cost of hepatitis C virus

AIM This study compared PR and NB in predicting HCV patient costs. The objective of this study was to predict the direct cost of the HCV patient in Iran. BACKGROUND Hepatitis C virus (HCV) is a common and expensive infectious disease in Iran. Cost associated with HCV and its complications has not been well characterized. Analysis of cost data is important in providing consistent information t...

متن کامل

Hepatitis C virus and skin

Nowadays viral hepatitis is one of the most common and important causes of chronic liver disorders in the world. Extrahepatic manifestations of viral hepatitis consist a main part of the disease. The main viruses causing hepatitis include Hepatitis A, B and C viruses. Herein common skin manifestations in hepatitis C virus (HCV) are discussed. Chronic hepatitis causes skin disorders both directl...

متن کامل

The Absence of Hepatitis C Virus Infection Among Patients with Hepatitis B virus in Mashhad, Iran

Background and Aims: Many studies have provided evidence for the role of hepatitis B and C viruses in the development of liver cancer. Although the routine treatment is available for both conditions, no definite guideline is available to treat patients dually infected with HBV and HCV. This study was performed to determine the frequency of HBV/HCV-coinfection in Mashhad, North-East of Iran. Mat...

متن کامل

Merging models of hepatitis C virus pathogenesis.

Chronic hepatitis C virus (HCV) infection is one of the major causes for development of liver cirrhosis and end-stage liver disease. This article reviews two contrasting models of HCV pathogenesis, discusses the merits of each, and presents a rationale for combining the two models into one. Any successful model of HCV pathogenesis must explain how the characteristic features of cirrhosis and en...

متن کامل

Experimental models to study the immunobiology of hepatitis C virus.

Effective host immune responses are essential for the control of hepatitis C virus (HCV) infection and persistence of HCV has indeed been attributed to their failure. In recent years, several in vitro and in vivo experimental models have allowed studies of host immune responses against HCV. Numerous observations derived from these models have improved our understanding of the mechanisms respons...

متن کامل

Hepatitis C Virus and Vaccine Development

The prevalence of Hepatitis C virus (HCV) is approximately 3% around the world. This virus causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The effectiveness of interferon-α and ribavirin therapy is about 50% and is associated with significant toxicity and cost. Hence, generating new vaccines or drugs is an obligation. However, there is no vaccine available for clinical u...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
gastroenterology and hepatology from bed to bench

جلد ۵، شماره ۱، صفحات ۰-۰

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023